NGNE: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Total research and development expenses	54,372	-
Total general and administrative expenses	21,427	-
Other income	10,183	-
Net loss	-65,616	-
Stock-based compensation expense	10,821	7,456
Depreciation and amortization of property and equipment	2,267	1,503
Asset impairment	0	0
Non-cash operating lease expense	606	399
Amortization of finance lease right-of-use assets	38	26
Amortization and accretion of premiums/discounts on held-to-maturity investments	4,036	3,220
Change in contingent value rights liability	-744	78
Prepaid expenses and other current assets	1,366	949
Other assets	88	121
Accounts payable	218	719
Accrued expenses and other liabilities	334	-31
Operating lease liabilities	-2,178	-1,433
Net cash used in operating activities	-59,744	-40,236
Purchases of property and equipment	1,055	928
Purchases of held-to-maturity investments	226,750	149,367
Proceeds from maturities of held-to-maturity investments	212,200	112,700
Net cash used in investing activities	-15,605	-37,595
Proceeds from sale of common stock in at-the-market sales agreement, net of offering costs	9,800	-
Payment of deferred offering costs related to at-the-market sales agreement	166	-
Offering costs in connection with pre-closing financing	0	0
Transaction costs related to reverse merger	0	0
Proceeds from the issuance of common stock upon exercise of options	176	87
Principal payments on finance leases	42	29
Net cash provided by (used in) financing activities	9,768	58
Net decrease in cash, cash equivalents and restricted cash	-65,581	-77,773
Cash and cash equivalents at beginning of period	136,925	-
Cash and cash equivalents at end of period	71,344	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

NGNE: the cashflow